CoChat

Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs

Open access
Campana, D, Nori, F, Pezzilli, R, Piscitelli, L, Santini, D, Brocchi, E, Corinaldesi, R, Tomassetti, P · 2008 · Endocrine Related Cancer
Cited by 74

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Gastric endocrine tumors associated with autoimmune chronic atrophic gastritis (gastric carcinoid type I) are almost exclusively benign lesions with little risk of deep invasion of the gastric parietal wall. For this reason, the role of octreotide in the treatment of these neoplastic lesions is controversial. Nine patients with more than five type I gastric endocrine tumors each <1 cm in size, without invasion of the muscularis propria and with Ki-67 index lower than 3%, were treated with long-acting somatostatin analogs for 12 months. After 6 months and again after 12 months, all the patients underwent upper gastrointestinal (GI) endoscopy with multiple biopsies. The plasma chromogranin A (CgA) levels and the gastrin levels in the serum were also determined. In all patients, the gastric neoplastic lesions disappeared after 12 months of somatostatin analog therapy. We also observed a significant reduction of CgA and gastrin levels at 6 and at 12 months of therapy as compared with the baseline values. We demonstrate that somatostatin analog treatment provokes the pathological regression of type I gastric carcinoids. This therapeutic approach should be considered as a valid option in selected patients with multiple type I gastric endocrine tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1677/erc-07-0251

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 74

Metadata

Authors
Campana, D., Nori, F., Pezzilli, R., Piscitelli, L., Santini, D., Brocchi, E., Corinaldesi, R., & Tomassetti, P.
Venue
Endocrine Related Cancer
Published
2008-03-01
Volume
15
Issue
1
Pages
337-342
ISSN
  • 1351-0088 (ISSN-L)
  • 1479-6821
OpenAlex
W2117796497
Cited by
74
References
1
FWCI
4.16
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs. https://app.cochat.ai/papers/10.1677/erc-07-0251
The paper
Campana, D., Nori, F., Pezzilli, R., Piscitelli, L., Santini, D., Brocchi, E., Corinaldesi, R., & Tomassetti, P. (2008). Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs. Endocrine Related Cancer. https://doi.org/10.1677/erc-07-0251

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.